Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Standard dosing is more effective for severe alopecia areata in children, but unorthodox dosing can be safe and considered if needed.

Low-dose methotrexate is generally safe but can cause mild to severe side effects, and folic acid can reduce these risks.

Patients with rheumatoid arthritis using tofacitinib had more serious side effects than those with alopecia areata.

Thalidomide works best for skin lupus not helped by antimalarials, but has many side effects; other treatments are less effective, especially if patients also have systemic lupus.

The article suggests managing interferon beta therapy side effects in MS with dose adjustments, medications, and patient education.

Tofacitinib effectively treated a woman's severe symptoms from a rare autoimmune condition.

Dual-targeted therapy is effective and safe for difficult-to-treat inflammatory bowel disease.

Tofacitinib is a promising and safe treatment for moderate to severe alopecia areata.

Flutamide worked better than finasteride for reducing excessive hair growth in women, but had more side effects.

Tofacitinib taken by mouth helps treat hair loss in children.

Tofacitinib is an effective and safe treatment for alopecia areata.

Flutamide helps with prostate cancer and some skin conditions but can harm the liver.

Oral tofacitinib has a moderate success rate and is generally safe for treating hair loss in some patients.

Tofacitinib is effective and safe for long-term treatment of severe alopecia areata, with many patients achieving complete hair regrowth.

The document concludes that managing side effects of MS therapies is crucial for treatment success and patient adherence.

Lenalidomide effectively and safely treats skin symptoms in pediatric lupus, reducing the need for prednisone.

High-dose mizoribine effectively controls symptoms in adolescents with lupus while reducing steroid use, with manageable side effects.

Tofacitinib may help treat severe hair loss, but more research is needed.

An 8-year-old with severe hair loss regrew all hair after six months of tofacitinib treatment.

Half of the patients treated with a specific drug for skin cancer experienced hair loss not related to the drug's dosage.

A patient with lupus and long-term hair loss saw significant hair regrowth after using the drug tofacitinib.

Isotretinoin with tacrolimus may be more effective short-term for treating frontal fibrosing alopecia than finasteride with tacrolimus.

Tofacitinib partially improved hair regrowth in a patient with severe hair loss.

Tofacitinib regrew hair in a man with total hair loss but raised cytokine levels, needing more research on possible side effects.

Tofacitinib may help treat both alopecia areata and inflammatory bowel disease.

Tofacitinib and baricitinib had an acceptable level of side effects in rheumatoid arthritis patients.

Low-dose flutamide helps reduce excessive hair growth and is even more effective with birth control, without bad effects on blood fats.

Tofacitinib caused significant hair regrowth in adolescents with alopecia universalis who didn't respond to other treatments.